Soft‐tissue sarcoma in adults: an update on the current state of histiotype‐specific management in an era of personalized medicine

AC Gamboa, A Gronchi… - CA: a cancer journal for …, 2020 - Wiley Online Library
Soft‐tissue sarcomas (STS) are rare tumors that account for 1% of all adult malignancies,
with over 100 different histologic subtypes occurring predominately in the trunk, extremity …

Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology

M Von Mehren, RL Randall, RS Benjamin… - Journal of the National …, 2018 - jnccn.org
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a
heterogenous mix of clinical and pathologic characteristics. STS can develop from fat …

Radiation therapy for treatment of soft tissue sarcoma in adults: executive summary of an ASTRO clinical practice guideline

KE Salerno, KM Alektiar, EH Baldini, M Bedi… - Practical radiation …, 2021 - Elsevier
Purpose This guideline provides evidence-based recommendations addressing the
indications for radiation therapy (RT), sequencing of local therapies, and appropriate dose …

[HTML][HTML] The biology and treatment of leiomyosarcomas

WGJ Kerrison, K Thway, RL Jones… - Critical Reviews in …, 2023 - Elsevier
Leiomyosarcoma (LMS) is a soft tissue sarcoma of smooth muscle origin that can arise in
multiple anatomical sites and is broadly classified as extra-uterine LMS or uterine LMS …

A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma

A Kalbasi, M Kamrava, FI Chu, D Telesca… - Clinical Cancer …, 2020 - AACR
Purpose: In a single-institution phase II study, we evaluated the safety of a 5-day dose-
equivalent neoadjuvant radiotherapy (RT) regimen for high-risk primary soft tissue sarcoma …

[HTML][HTML] The prognostic relevance of MRI characteristics in myxofibrosarcoma patients treated with neoadjuvant radiotherapy

SG van Ravensteijn, MJL Nederkoorn, TCP Wal… - Cancers, 2023 - mdpi.com
Simple Summary Myxofibrosarcomas (MFS) are malignant soft tissue tumors, frequently
located in the extremities. Owing to the infiltrative growth pattern of MFS, neoadjuvant …

[HTML][HTML] Prognostic Factors in Extremity Soft Tissue Sarcomas Treated with Radiotherapy: Systematic Review of the Literature

A Lebas, C Le Fèvre, W Waissi, I Chambrelant… - Cancers, 2023 - mdpi.com
Simple Summary Soft tissue sarcomas of the extremities are rare tumors with various
prognostic factors. The gold standard curative treatment relies on surgery with negative …

Identification of predictors for wound complications following preoperative or postoperative radiotherapy in extremity soft tissue sarcoma

MG Stevenson, JF Ubbels, J Slump, MA Huijing… - European Journal of …, 2018 - Elsevier
Introduction In extremity soft tissue sarcoma (ESTS), external beam radiotherapy (EBRT) has
been used in addition to limb-sparing surgery (LSS). This study aims to identify predictors for …

Radiotherapy is associated with improved survival in patients with synovial sarcoma undergoing surgery: A national cancer database analysis

AA Gingrich, AS Marrufo, Y Liu, CS Li… - Journal of Surgical …, 2020 - Elsevier
Background Previous studies have demonstrated an association of perioperative
radiotherapy (RT) with improved survival in patients with synovial sarcoma (SS) undergoing …

Limb‐sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high‐grade, extremity soft‐tissue sarcoma from the NCDB and SEER

SJ Ramey, R Yechieli, W Zhao, J Kodiyan… - Cancer …, 2018 - Wiley Online Library
Small randomized trials have not shown an overall survival (OS) difference among local
treatment modalities for patients with extremity soft‐tissue sarcomas (E‐STS) but were …